A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)

NCT01614782 ·Status: TERMINATED ·Phase: PHASE1

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

NCT00533481 ·Status: COMPLETED ·Phase: PHASE2

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

NCT00482196 ·Status: COMPLETED ·Phase: PHASE2

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

NCT03661879 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ·Status: COMPLETED ·Phase: PHASE2

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2

Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight

NCT02958085 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

NCT07205900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)

NCT00131430 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients

NCT07009171 ·Status: RECRUITING ·Phase: PHASE2

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

NCT03308721 ·Status: COMPLETED ·Phase: PHASE1

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

NCT02870231 ·Status: COMPLETED ·Phase: PHASE1

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

NCT02835235 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3502970 in Healthy Overweight and Obese Participants

NCT05313802 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity

NCT04707313 ·Status: COMPLETED ·Phase: PHASE2

Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

NCT01133210 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)

NCT00482638 ·Status: COMPLETED ·Phase: PHASE2

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

NCT01044108 ·Status: TERMINATED ·Phase: PHASE1

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Zonisamide for Weight Reduction in Obese Adults

NCT00275834 ·Status: COMPLETED ·Phase: NA

Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)

NCT05035095 ·Status: COMPLETED ·Phase: PHASE3

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

NCT04010786 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

NCT07002905 ·Status: COMPLETED ·Phase: PHASE2

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

NCT02941042 ·Status: COMPLETED ·Phase: PHASE1

A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.

NCT01195792 ·Status: COMPLETED ·Phase: PHASE2